Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.
about
Blood pressure control for diabetic retinopathyAnti-vascular endothelial growth factor for proliferative diabetic retinopathyLaser photocoagulation for proliferative diabetic retinopathyAnti-vascular endothelial growth factor for proliferative diabetic retinopathyBlood pressure control for diabetic retinopathyEpidemiological issues in diabetic retinopathyDoes tight control of systemic factors help in the management of diabetic retinopathy?Diabetic retinopathy and systemic factorsParaoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetesHow can we improve the management of vascular risk in type 2 diabetes: insights from FIELDPrimary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort studyDiabetic macular oedema: clinical risk factors and emerging genetic influences.Fenofibrate and Diabetic Retinopathy.Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial.View 1: should this patient receive laser treatment?The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark.Clinical outcomes following laser photocoagulation treatment for diabetic retinopathy at a large Australian ophthalmic hospital.Diabetic retinopathy: should this patient receive laser treatment? Overview.Current and future pharmacological intervention for diabetic retinopathy.Diabetic eye disease.Diabetic macular oedema: a clinical overview.Diabetic retinopathy: treatment and prevention.Emerging pharmacotherapies for diabetic macular edema.Diabetic retinopathy: an updateRapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial.Emerging drugs for diabetic retinopathy.Ocular telehealth initiatives in diabetic retinopathy.Pharmacologic therapies for diabetic retinopathy and diabetic macular edemaWhy do patients still require surgery for the late complications of Proliferative Diabetic Retinopathy?Selective retina therapy (SRT) for clinically significant diabetic macular edema.Biomarkers in Diabetic RetinopathyEffects of medical therapies on retinopathy progression in type 2 diabetesEffect of macular photocoagulation on visual acuity of Omani patients with clinically significant macular edema.Multimodality analysis of Hyper-reflective Foci and Hard Exudates in Patients with Diabetic Retinopathy.The Role of Systemic Risk Factors in Diabetic RetinopathyPrognostic factors of short-term outcomes of intravitreal ranibizumab in diabetic macular edema.Current and future management of diabetic retinopathy: a personalized evidence-based approach.Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy.Dyslipidemia and diabetic retinopathy.Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone
P2860
Q24186434-3F953728-088C-4D69-87D3-F360AE4CFF4EQ24187858-655969EC-B3AC-4997-994E-B8A38A80993EQ24187871-AF918F08-B684-4C6A-BC4C-0E04094F2F2EQ24236189-7D785F47-A961-4F42-8A78-E258C72421AEQ24245872-E838CAC4-44E2-4457-82C8-8EDC7A62CA31Q27003941-7E800E48-AC8A-407A-9CA0-8901674305ACQ28074223-26B6651B-CBE4-40D0-8A1F-38822524B7BCQ28082046-963F59FF-4D21-44A2-A36D-DDB9A7D272D6Q28210667-B6FD91F6-B7D8-4BED-B276-50BD28DA259CQ28258705-A9B18D91-FCC8-4A39-8ADC-695341C49520Q28661253-63C45137-B755-46BF-961B-057D15E3330FQ30234323-318762C2-0501-44D9-B050-1C0137E95530Q30248492-58BE1E55-7193-4D0A-AF6C-239CB61C62FBQ31018013-7DDC0763-750B-4F8D-B300-5980FA9917DFQ31049544-AE27E45C-0BDC-4235-AA7F-CEF52FC9A4A4Q31104469-8E2987E1-178D-4EB9-9834-DB11E69883CFQ31150631-A568BF5D-98A6-49CB-A8A4-0630411E1E8BQ33198523-AA0ADBC5-F299-4A2C-AD0A-341804FBF004Q33216425-DFB97350-1550-494A-BC18-968FD8F401A3Q33231783-78E5E609-1F2B-4009-831A-4F94F7F9892BQ33269486-0CF2243D-A5EF-4492-A105-38C5D97431E9Q33302529-516AA291-9B9A-430F-862D-EC1BA578C79BQ33304852-DF6EF172-D559-4CC3-91D9-96AF3623787BQ33328784-34F65673-B9AF-402A-8F98-ECD65FA84B4CQ33368822-A1CA756E-DC9E-4A38-86C8-22BCA405663AQ33388498-AF2F09A2-ACF0-4BC1-92AE-EF5858988B3FQ33488380-91831E9B-824C-42F7-AC5B-AB2FD357175FQ33492340-294BBDE8-79D3-4EE3-9E26-A0C82C32A5D3Q33522560-8D3A3F9B-CBF8-47A8-94E2-8567E6D6849CQ33555931-A310471B-ABC4-4899-BE97-F11B2366DD1AQ33583030-A02C45F7-BEEA-4A48-B75F-CEFAD6D53B3DQ33620031-F0BAF865-DA99-48AE-B47B-277584DBE9C6Q33645419-D1E27DF5-6176-46B7-93B4-9B29B0A4217BQ33685610-55FDB224-7D8C-44E2-B211-510E791201CBQ33689773-03EE26B7-237B-4351-BD1C-23C1B3B74F41Q33706098-4B01ECF9-7B16-43BC-A64F-89A3DC060364Q33738829-2B8B1A81-A1E9-4F6E-B824-221FB5050E77Q33740088-845950FC-795D-49D7-B29B-4E9E42693B19Q33776171-A7FB3500-A8BD-4334-9E19-F2BF54342C97Q33853527-11904738-1D30-4F7B-9E53-1585F14885A9
P2860
Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Association of elevated serum ...... pathy Study (ETDRS) Report 22.
@ast
Association of elevated serum ...... pathy Study (ETDRS) Report 22.
@en
type
label
Association of elevated serum ...... pathy Study (ETDRS) Report 22.
@ast
Association of elevated serum ...... pathy Study (ETDRS) Report 22.
@en
prefLabel
Association of elevated serum ...... pathy Study (ETDRS) Report 22.
@ast
Association of elevated serum ...... pathy Study (ETDRS) Report 22.
@en
P2093
P1433
P1476
Association of elevated serum ...... pathy Study (ETDRS) Report 22.
@en
P2093
B J Hoogwerf
F L Ferris
N A Remaley
R P Murphy
P304
P356
10.1001/ARCHOPHT.1996.01100140281004
P407
P577
1996-09-01T00:00:00Z